ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,420.26
-0.22%
Dow Jones
40,003.59
0.34%
Gold vs US Dollar
2,413.935
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,873.87
-0.31%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Pozen, Inc. (MM) (POZN)

  7. Pozen, Inc. (MM) (POZN) News

Pozen, Inc. (MM) (POZN)

Pozen, Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:POZN
DateTimeSourceHeadlineSymbolCompany
14/03/201619:08Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:POZNPozen, Inc. (MM)
14/03/201617:23Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:POZNPozen, Inc. (MM)
14/03/201617:21Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:POZNPozen, Inc. (MM)
19/10/200914:01PR Newswire (US)Patients Taking VIMOVO(TM) Showed a Decrease in Incidence of NSAID-Associated UlcersNASDAQ:POZN
16/10/200913:45Dow Jones NewsAstraZeneca Submits EU Marketing Application For VimovoNASDAQ:POZNPozen Inc.
31/08/200913:39Dow Jones NewsPozen Earns $10 Million From AstraZeneca As FDA Accepts Drug ApplicationNASDAQ:POZNPozen Inc.
30/06/200913:57Dow Jones NewsAstraZeneca Partner Pozen Submits PN400 New Drug ApplicationNASDAQ:POZNPozen Inc.
30/06/200913:57Dow Jones NewsAstraZeneca Partner Pozen Submits PN400 New Drug ApplicationNASDAQ:POZNPozen Inc.
08/06/200718:00PR Newswire (US)Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple AttacksNASDAQ:POZN
02/05/200720:12PR Newswire (US)Trexima(TM) (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine AttacksNASDAQ:POZN
02/05/200720:09PR Newswire (US)Trexima(TM) (Sumatriptan/Naproxen Sodium) Provided Relief of Both Traditional and Non-traditional Migraine SymptomsNASDAQ:POZN
03/05/200622:21PR Newswire (US)American Stock Exchange to Trade Options on Six SecuritiesNASDAQ:POZN
 Showing the most relevant articles for your search:NASDAQ:POZN

Your Recent History

LSE
BOD
Botswana Diamonds
LSE
MXCS
Maxcyte
BITMOT
834357
Ireland Tf 1,3% Mg33 Eur
COIN
TITAUSD
Titan Hunters
BIT
MET
Met Extra
LSE
STAF
Staffline
HUOB
STPTBTC
Standard Tokenization Protocol
USOTC
CBWTF
Auxly Cannabis (QB)
LATK
CFTUSDT
CryptoForecast
NYSE
NEM
Newmont
COIN
ZUMEUR
HITB
MASKUSD
Mask Network
TIDE
WINGSBTC
BIT
1FRA
Fraport
GATE
SBTCBTC
Super Bitcoin
CSE
NSG
Northstar Gold
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved